News & Updates
Filter by Specialty:

Early fruit consumption may ward off late-life blues
Increased fruit consumption among middle-aged men and women has been linked to reduced likelihood of depressive symptoms in old age in a large Singapore study.
Early fruit consumption may ward off late-life blues
03 Aug 2024
Asian patients with HFmrEF at high risk of atherosclerotic burden
Among Asian patients with heart failure (HF), those experiencing HF with mildly reduced ejection fraction (HFmrEF) constitute a substantial burden, according to a Singapore study.
Asian patients with HFmrEF at high risk of atherosclerotic burden
03 Aug 2024
One-time sigmoidoscopy fends off colorectal cancer risk for up to 2 decades
Once-only screening with flexible sigmoidoscopy appears to provide prolonged protection against colorectal cancer (CRC), reducing both incidence and mortality rates for up to 2 decades, according to the updated results of the UK Flexible Sigmoidoscopy Screening Trial (UKFSST).
One-time sigmoidoscopy fends off colorectal cancer risk for up to 2 decades
02 Aug 2024
Dostarlimab plus chemo extends survival in advanced/recurrent endometrial cancer
Treatment with dostarlimab combined with carboplatin‒paclitaxel significantly improves overall survival (OS) among patients with primary advanced or recurrent endometrial cancer (EC), with no new safety signals, results of the RUBY trial have shown.
Dostarlimab plus chemo extends survival in advanced/recurrent endometrial cancer
02 Aug 2024
MIRV treatment effects sustained in PROC despite dose modifications
In a post hoc analysis of the phase III MIRASOL (GOG 3045/ENGOT-ov55) trial, mirvetuximab soravtansine (MIRV) continues to demonstrate clinically meaningful improvements in survival and objective response rate (ORR) in women with platinum-resistant ovarian cancer (PROC) with high folate receptor-alpha (FRα) expression who necessitated dose modifications.